The scope of the EMEA conference is on EU clinical trials legislation and its implementation in the context of clinical trials of medicinal products.
The objectives of the EMEA conference:
provide an overview of the experience to date with the operation of the Directives 2001/20/EC and 2005/28/EC
the experience with their implementing texts
describe problems encountered
make recommendations for the future
Participants for this EMEA conference are selected by stakeholder groups and by invitation only.
For further information check the EMEA website. The conference programme is available to download here:

